Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal Avastin for exudative maculopathies
2005-006182-14Phase 2Active
- Sponsor
- University of Udine
- Start
- Feb 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bevacizumab in diabetic macular edema (DME), Vein occlusion (RVO), age-related macular degeneration (AMD) and 2 more, sponsored by University of Udine. Started Feb 2006; status: active.
02
Drugs
bevacizumab
03
Conditions
diabetic macular edema (DME)Vein occlusion (RVO)age-related macular degeneration (AMD)Subretinal neovascularizationretinal angiomatous proliferation (RAP)
Beyond the preview
Go deeper on 2005-006182-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-006182-14.